Praxis precision medicines to present at stifel's 4th annual cns day

Boston, march 21, 2022 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in a fireside chat at stifel's 4th annual cns day on tuesday, march 29, 2022 at 11:30 a.m. et.
PRAX Ratings Summary
PRAX Quant Ranking